{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T23:12:31Z","timestamp":1769037151158,"version":"3.49.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1016\/j.atherosclerosis.2010.06.021","type":"journal-article","created":{"date-parts":[[2010,6,21]],"date-time":"2010-06-21T00:25:03Z","timestamp":1277079903000},"page":"352-362","source":"Crossref","is-referenced-by-count":29,"title":["Predicting the risk of coronary heart disease. II: The role of novel molecular biomarkers and genetics in estimating risk, and the future of risk prediction"],"prefix":"10.1016","volume":"213","author":[{"given":"THS","family":"Dent","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2010.06.021_bib1","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1001\/archinte.161.22.2657","article-title":"The real contribution of the major risk factors to the coronary epidemics","volume":"161","author":"Magnus","year":"2001","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.atherosclerosis.2010.06.021_bib2","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1093\/aje\/kwh101","article-title":"Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker","volume":"159","author":"Pepe","year":"2004","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.atherosclerosis.2010.06.021_bib3","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/sim.2929","article-title":"Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond","volume":"27","author":"Pencina","year":"2008","journal-title":"Statist Med"},{"key":"10.1016\/j.atherosclerosis.2010.06.021_bib4","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1056\/NEJMoa032804","article-title":"C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease","volume":"350","author":"Danesh","year":"2004","journal-title":"NEJM"},{"key":"10.1016\/j.atherosclerosis.2010.06.021_bib5","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1001\/archinte.165.21.2473","article-title":"C-reactive protein and risk of cardiovascular disease in men and women from the Framingham Heart Study","volume":"165","author":"Wilson","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.atherosclerosis.2010.06.021_bib6","first-page":"1","article-title":"Critical appraisal of CRP measurement for the prediction of coronary heart disease events: new data and systematic review of 31 prospective cohorts","author":"Shah","year":"2008","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.atherosclerosis.2010.06.021_bib7","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S0140-6736(09)61717-7","article-title":"C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis","volume":"375","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2010.06.021_bib8","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1161\/CIRCOUTCOMES.108.831198","article-title":"C-reactive protein and reclassification of cardiovascular risk in the outcomes Framingham Heart Study","volume":"1","author":"Wilson","year":"2008","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.atherosclerosis.2010.06.021_bib9","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1001\/jama.2009.954","article-title":"Genetic loci associated with C-reactive protein levels and risk of coronary heart disease","volume":"302","author":"Elliot","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2010.06.021_bib10","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1001\/jama.294.14.1799","article-title":"Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis","volume":"294","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2010.06.021_bib11","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1136\/bmj.325.7374.1202","article-title":"Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis","volume":"325","author":"Wald","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.atherosclerosis.2010.06.021_bib12","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1001\/jama.288.16.2015","article-title":"Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis","volume":"288","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2010.06.021_bib13","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1093\/eurheartj\/ehi502","article-title":"Plasma N-terminal pro-brain natriuretic peptide concentration predicts coronary events in men at work: a report from the BELSTRESS study","volume":"26","author":"De Sutter","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.atherosclerosis.2010.06.021_bib14","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1001\/jama.293.13.1609","article-title":"N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults","volume":"293","author":"Kistorp","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2010.06.021_bib15","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1161\/CIRCULATIONAHA.109.884866","article-title":"B-type natriuretic peptides and cardiovascular risk: systematic review and meta-analysis of 40 prospective studies","volume":"120","author":"Di Angelantonio","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2010.06.021_bib16","doi-asserted-by":"crossref","first-page":"4525","DOI":"10.1210\/jc.2003-030636","article-title":"Low-density lipoprotein size and cardiovascular disease: a reappraisal","volume":"88","author":"Sacks","year":"2003","journal-title":"J Clin Endocrinol Metabol"},{"key":"10.1016\/j.atherosclerosis.2010.06.021_bib17","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/dmrr.694","article-title":"Small, dense low-density-lipoproteins and the metabolic syndrome","volume":"23","author":"Rizzo","year":"2007","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.atherosclerosis.2010.06.021_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/qjmed\/hci154","article-title":"Low-density lipoprotein size and cardiovascular risk assessment","volume":"99","author":"Rizzo","year":"2006","journal-title":"Q J Med"},{"key":"10.1016\/j.atherosclerosis.2010.06.021_bib19","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1365-2796.2006.01644.x","article-title":"Associations between apolipoprotein B, apolipoprotein AI, the apolipoprotein B\/AI ratio and coronary heart disease: a literature-based meta-analysis of prospective studies","volume":"259","author":"Thompson","year":"2006","journal-title":"J Intern Med"},{"key":"10.1016\/j.atherosclerosis.2010.06.021_bib20","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1001\/jama.298.11.1300","article-title":"Association of apolipoprotein E genotypes with lipid levels and coronary risk","volume":"298","author":"Bennett","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2010.06.021_bib21","doi-asserted-by":"crossref","first-page":"159","DOI":"10.4065\/82.2.159","article-title":"Association between lipoprotein-associated phospholipase a2 and cardiovascular disease: a systematic review","volume":"82","author":"Garza","year":"2007","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.atherosclerosis.2010.06.021_bib22","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1001\/jama.2009.1063","article-title":"Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality","volume":"302","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2010.06.021_bib23","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1161\/CIRCULATIONAHA.107.715698","article-title":"Extreme lipoprotein(a) levels and risk of myocardial infarction in the general population: the Copenhagen City Heart Study","volume":"117","author":"Kamstrup","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2010.06.021_bib24","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1056\/NEJMoa043161","article-title":"Cystatin C and the risk of death and cardiovascular events among elderly persons","volume":"352","author":"Shlipak","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2010.06.021_bib25","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1373\/clinchem.2007.094425","article-title":"Serum uric acid and risk of cardiovascular mortality: a prospective long-term study of 83,683 Austrian men","volume":"54","author":"Strasak","year":"2008","journal-title":"Clin Chem"},{"key":"10.1016\/j.atherosclerosis.2010.06.021_bib26","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.ijcard.2007.11.094","article-title":"Serum uric acid is an independent predictor for all major forms of cardiovascular death in 28,613 elderly women: a prospective 21-year follow-up study","volume":"125","author":"Strasak","year":"2008","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.atherosclerosis.2010.06.021_bib27","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1161\/01.STR.0000221716.55088.d4","article-title":"Uric acid is a risk factor for myocardial infarction and stroke: the Rotterdam study","volume":"37","author":"Bos","year":"2006","journal-title":"Stroke"},{"key":"10.1016\/j.atherosclerosis.2010.06.021_bib28","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.atherosclerosis.2005.01.018","article-title":"Hyperuricemia as a risk factor on cardiovascular events in Taiwan: The Chin-Shan Community Cardiovascular Cohort Study","volume":"183","author":"Chien","year":"2005","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2010.06.021_bib29","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.atherosclerosis.2006.04.006","article-title":"Alanine aminotransferase predicts coronary heart disease events: a 10-year follow-up of the Hoorn Study","volume":"191","author":"Schindhelm","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2010.06.021_bib30","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1161\/ATVBAHA.107.152298","article-title":"Gamma-glutamyltransferase is associated with incident vascular events independently of alcohol intake: analysis of the British Women's Heart and Health Study and Meta-Analysis","volume":"27","author":"Fraser","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2010.06.021_bib31","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.atherosclerosis.2008.01.019","article-title":"The value of gamma-glutamyltransferase in cardiovascular risk prediction in men without diagnosed cardiovascular disease or diabetes","volume":"201","author":"Wannamethee","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2010.06.021_bib32","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1161\/01.CIR.0000125690.80303.A8","article-title":"Clinical usefulness of very high and very low levels of C-reactive protein across the full range of Framingham risk scores","volume":"109","author":"Ridker","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2010.06.021_bib33","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1001\/archinte.166.13.1368","article-title":"An assessment of incremental coronary risk prediction using C-reactive protein and other novel risk markers","volume":"166","author":"Folsom","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.atherosclerosis.2010.06.021_bib34","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1056\/NEJMoa055373","article-title":"Multiple biomarkers for the prediction of first major cardiovascular events and death","volume":"355","author":"Wang","year":"2006","journal-title":"NEJM"},{"key":"10.1016\/j.atherosclerosis.2010.06.021_bib35","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1001\/jama.2009.943","article-title":"Novel and conventional biomarkers for prediction of incident cardiovascular events in the community","volume":"302","author":"Melander","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2010.06.021_bib36","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1056\/NEJMoa0707064","article-title":"Use of multiple biomarkers to improve the prediction of death from cardiovascular causes","volume":"358","author":"Zethelius","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2010.06.021_bib37","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.tem.2005.02.009","article-title":"Genetics of human hypertension","volume":"16","author":"Agarwal","year":"2005","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.atherosclerosis.2010.06.021_bib38","doi-asserted-by":"crossref","first-page":"319S","DOI":"10.1093\/ajh\/6.11.319S","article-title":"Genetic basis of familial dyslipidemia and hypertension: 15-year results from Utah","volume":"6","author":"Williams","year":"1993","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.atherosclerosis.2010.06.021_bib39","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1001\/jama.291.18.2204","article-title":"Parental cardiovascular disease as a risk factor for cardiovascular disease in middle-aged adults: a prospective study of parents and offspring","volume":"291","author":"Lloyd-Jones","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2010.06.021_bib40","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/01.hco.0000160373.77190.f1","article-title":"Molecular basis of coronary artery disease","volume":"20","author":"Wang","year":"2005","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.atherosclerosis.2010.06.021_bib41","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1056\/NEJMcibr1002359","article-title":"Chromosome 9p21 and coronary artery disease","volume":"362","author":"McPherson","year":"2010","journal-title":"NEJM"},{"key":"10.1016\/j.atherosclerosis.2010.06.021_bib42","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1136\/bmj.39609.449676.25","article-title":"Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2","volume":"336","author":"Hippisley-Cox","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.atherosclerosis.2010.06.021_bib43","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1056\/NEJMsa0708739","article-title":"Polygenes, risk prediction, and targeted prevention of breast cancer","volume":"358","author":"Pharoah","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2010.06.021_bib44","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1056\/NEJMoa0907727","article-title":"Performance of common genetic variants in breast-cancer risk models","volume":"362","author":"Wacholder","year":"2010","journal-title":"NEJM"},{"key":"10.1016\/j.atherosclerosis.2010.06.021_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1469-1809.2007.00359.x","article-title":"The use of meta-analysis risk estimates for candidate genes in combination to predict coronary heart disease risk","volume":"71","author":"Drenos","year":"2007","journal-title":"Ann Hum Genet"},{"key":"10.1016\/j.atherosclerosis.2010.06.021_bib46","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1097\/GIM.0b013e31812eece0","article-title":"The impact of genotype frequencies on the clinical validity of genomic profiling for predicting common chronic diseases","volume":"9","author":"Janssens","year":"2007","journal-title":"Genet Med"},{"key":"10.1016\/j.atherosclerosis.2010.06.021_bib47","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1373\/clinchem.2007.095489","article-title":"Chromosome 9p21.3 coronary heart disease locus genotype and prospective risk of CHD in healthy middle-aged men","volume":"54","author":"Talmud","year":"2008","journal-title":"Clin Chem"},{"key":"10.1016\/j.atherosclerosis.2010.06.021_bib48","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1373\/clinchem.2006.074591","article-title":"Candidate gene genotypes, along with conventional risk factor assessment, improve estimation of coronary heart disease risk in healthy UK men","volume":"53","author":"Humphries","year":"2007","journal-title":"Clin Chem"},{"key":"10.1016\/j.atherosclerosis.2010.06.021_bib49","doi-asserted-by":"crossref","first-page":"65","DOI":"10.7326\/0003-4819-150-2-200901200-00003","article-title":"Cardiovascular disease risk prediction with and without knowledge of genetic variation at chromosome 9p21.3","volume":"150","author":"Paynter","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.atherosclerosis.2010.06.021_bib50","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1056\/NEJMoa0706728","article-title":"Polymorphisms associated with cholesterol and riskof cardiovascular events","volume":"358","author":"Kathiresan","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2010.06.021_bib51","unstructured":"UK National Screening Committee. Criteria for appraising the viability, effectiveness and appropriateness of a screening programme (www.screening.nhs.uk\/criteria)."},{"key":"10.1016\/j.atherosclerosis.2010.06.021_bib52","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1016\/j.amjcard.2008.04.015","article-title":"Advances in the detection of rupture-prone plaque: the role of lipoprotein-associated phospholipase a2 in cardiovascular risk assessment","volume":"101","author":"Anderson","year":"2008","journal-title":"Am J Cardiol"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915010004399?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915010004399?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,10]],"date-time":"2018-12-10T08:20:29Z","timestamp":1544430029000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915010004399"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S0021915010004399"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2010.06.021","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]}}}